Chester County News and Community Website
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Scientific Officer Jeffrey Martini will address evidence gaps and regulatory barriers affecting drug repurposing at an Aug. 5 FDA public workshop …
Palvella Executive to Address FDA Drug Repurposing Barriers Read More
WASHINGTON, D.C. — The Food and Drug Administration selected Dexcom Inc. as the first participant in a federal pilot linking digital health-device oversight with a Medicare payment model that rewards …
FDA Selects Dexcom for Medicare Digital Health Pilot Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. highlighted new clinical data showing its XTRAC excimer laser significantly improved repigmentation outcomes in children with progressive vitiligo when paired with oral JAK …
STRATA Study Signals Expanded Market for Vitiligo Therapy Read More
WASHINGTON, D.C. — Federal regulators have cleared the way for certain pancreatic cancer patients to access an experimental drug earlier than usual, approving a rapid pathway that allows treatment outside …
FDA Fast-Tracks Access to Experimental Pancreatic Drug Read More
WASHINGTON, D.C. — Federal regulators are moving to speed up drug development by launching real-time clinical trials that allow safety data and results to be reviewed as studies are underway …
FDA Pushes Faster Drug Approvals With Real-Time Trials Read More
WASHINGTON, D.C. — Federal health officials are investing up to $139.4 million in new research to accelerate the development of mental health treatments, including emerging therapies such as digital tools, …
$139M Mental Health Push Aims to Speed New Treatments Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) will present new clinical data on its investigational therapy molgramostim at the ATS International Conference in Orlando, Florida, May 17–20, 2026, the company …
Savara to Present Molgramostim Data at ATS 2026 Conference Read More
WASHINGTON, D.C. — President Donald J. Trump has signed an executive order directing federal agencies to accelerate research, regulatory review, and potential patient access for experimental psychedelic drugs aimed at …
Trump Order Expands Federal Push on Psychedelic Therapies Read More
WASHINGTON, D.C. — Federal regulators are pushing thousands of companies and researchers to disclose missing clinical trial results, warning that gaps in reporting may distort how drugs and medical products …
FDA Presses Firms to Report Missing Clinical Trial Results Read More
WASHINGTON, D.C. — Federal regulators are moving to reduce the use of animal testing in drug development, issuing new guidance to help drugmakers adopt alternative methods that rely on human-based …
FDA Push to Replace Animal Testing Signals Major Shift Read More